Blaas- en urinewegentumoren
EFFORT Trial
Phase II prospective trial to evaluate the impact of 18FFDG-PET-CT in stratifying patients with primary muscle invasive bladder cancer and adapting the treatment accordingly.
- Inclusion criteria: Patients diagnosed with muscle invasive bladder cancer without distant metastasis on conventional imaging (CT chest, abdomen and pelvic MRI) and who are candidates for neoadjuvant chemotherapy and radical curative treatment.
- Local site Principal Investigator (Urology): prof. dr. Maarten Albersen
- Sub-investigator (Nuclear Medicine): prof. dr. Karolien Goffin
- Sub-investigator (Radiotherapy): prof. dr. Gert De Meerleer
- More information: dr. Loïc Baekelandt (PhD) via loic.baekelandt@uzleuven.be or 016 344722
Blaaspijnsyndroom
Er zijn momenteel geen studies beschikbaar.
Niertumoren
AUR87A
Glycosaminoglycan scores for surveillance of recurrence in Leibovich points ≥ 5 non-metastatic clear cell RCC
- Inclusion criteria: Tumour > 4 cm (or ≤ 4 cm only if RCC with radiological sign of venous tumour thrombus), elective/curative surgery
- Local site Principal Investigator: prof. dr. Maarten Albersen
- Sub-investigator: dr. Wies Vanderbruggen
- More information: NCT04006405
Overactieve blaas
CARE Studie
Continence Achieved through Recording of Electrophysiology (CARE) Study: A Prospective Study to Evaluate the Safety and Feasibility of using the Closed Loop Medical Sacral Nerve Stimulation System (the Repose™ System) in the treatment of Symptoms of Overactive Bladder
- Inclusie criteria: oa >= 18 jaar, Chronische OAB (> 12 maanden), Urgentie incontinentie, Onder stabiele OAB medicatie, Restblaasvolume <150cc, Geschikte kandidaat om een SNS-procedure te ondergaan
- Exclusie criteria: oa Hoofddiagnose stressincontinentie, Neurogene blaas, Interstitiële cystitis, Urinewegobstructie of urethrastrictuur, Botox injecties voor OAB (<9 maanden geleden)
- Local site Principal Investigator: prof. dr. Frank Van der Aa
- Sub-investigator: dr. Lucas Landen
- More information: ACTRN12622000999730
Penistumoren
BELPEN
Magnetic detection of sentinel lymph nodes in patients with penile cancer from Belgium
- Inclusion criteria: Penile cancer, suspected squamous cell carcinoma, ≥ pT1b G2 N0 M0, surgical intervention with a dynamic sentinel node biopsy procedure (using standard intradermal nanocolloid) being part of the surgical plan
- Local site Principal Investigator (Urology): prof. dr. Maarten Albersen
- Sub-investigator (Nuclear Medicine): prof. dr. Karolien Goffin
- More information: dr. Laura Elst (Phd): 016 34 73 58.
Prostaattumoren
LOMP2
Cytoreductive prostatectomy versus standard of care as a Local treatment option for primary Metastatic Prostate cancer: a phase II feasibility trial (LoMP II)
- Inclusion criteria: Local treatment option for primary metastatic hormone sensitive prostate cancer
- Study Principal Investigator: prof. dr. Piet Ost (UZ Gent)
- Local site Principal Investigator: prof. dr. Wouter Everaerts
- More information: NCT03655886
IWT-1
High precision imaging of prostate specific membrane antigen for personalized treatment in prostate cancer
- Inclusion criteria: Intermediate and high risk prostate cancer, histological proven, planned for radical prostatectomy with LAD
- Local site Principal Investigator (Nuclear Medicine): prof. dr. Karolien Goffin
- Sub-investigator (Urology): prof. dr. Steven Joniau
- More information: NCT03327675
Testistumoren
Er zijn momenteel geen studies beschikbaar.
Urinaire incontinentie
COLD INDUCED
Diagnostic tool and therapeutic strategy for acute cold-induced urgency (ACIU) part 2: optimizing the protocol
- Inclusion criteria: All patients with an overactive bladder for which a Urodynamic investigation is scheduled. Note that patients with prior pelvic floor surgery, neurological disorder or peripheral neuropathy are excluded from the study.
- Local site Principal Investigator: prof. dr. Wouter Everaerts
- Sub-investigator: prof. dr. Frank Van der Aa
- More information: dr. Lucas Landen
Urinaire retentie
Er zijn momenteel geen studies beschikbaar.
Urineweg-infecties
MINUS Trial
Multicentric study on Infections of the Urinary tract after Stent removal
- Inclusion criteria: Patients, 18 years of age and older who receive a ureteral stent during any endoscopic procedure will be approached to participate in the study
- Local site Principal Investigator: dr. Carl Van Haute
- Sub-investigator (Urology): prof. dr. Ben Van Cleynenbreugel
- More information: NCT05329883